<DOC>
	<DOCNO>NCT00222534</DOCNO>
	<brief_summary>Respiratory failure common consequence chronic obstructive pulmonary disease ( COPD ) . A concurrent metabolic alkalosis may worsen respiratory failure , high pH blood ( thus cerebrospinal fluid ) result weak respiratory drive . Use diuretic common cause metabolic alkalosis . When patient acute exacerbation respiratory failure also alkalotic , ( least theoretical ) reason low pH order increase respiratory drive . Among alternative , drug acetazolamide use purpose . In hospital tradition use acetazolamide indication , evidence effect treatment rather weak . Thus , aim trial evaluate effect acetazolamide adjuvant treatment hospitalize patient acute exacerbation respiratory failure combination metabolic alkalosis .</brief_summary>
	<brief_title>Acetazolamide Respiratory Failure Combination With Metabolic Alkalosis</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Alkalosis</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>Arterial pO2 8 kPa low , arterial pCO2 7 kPa high . Base Excess 8 mmmol/l high . Written inform consent Acetazolamide treatment regard obviously indicate obviously contraindicate Already use acetazolamide Moribund patient Unable give fully inform consent Allergy towards tablet content unable swallow tablet Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Respiratory Insufficiency</keyword>
	<keyword>Alkalosis</keyword>
</DOC>